140 related articles for article (PubMed ID: 3686442)
1. [Indications and effectiveness of combined therapy in chronic glomerulonephritis].
Ratner MIa; Biriukova LS; Makurov AI
Ter Arkh; 1987; 59(8):29-34. PubMed ID: 3686442
[No Abstract] [Full Text] [Related]
2. [Prolonged treatment of mesangioproliferative glomerulonephritis with a cytostatic agent and prednisolone and a combination of a cytostatic agent, prednisolone an anticoagulant and an antiaggregant].
Ratner MIa; Tomilina NA; Klinkman Kh; Shmitt E; Kreger E
Ter Arkh; 1980; 52(8):106-10. PubMed ID: 7256574
[No Abstract] [Full Text] [Related]
3. [The therapy of mesangiocapillary glomerulonephritis].
Ratner MIa; Fedorova ND; Biriukova LS; Makurov AI
Ter Arkh; 1995; 67(8):10-2. PubMed ID: 7482319
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of treatment of glomerulonephritis with anticoagulants, antiaggregants, cytostatics and methindol].
Riabov SI; Minkin RB; Rabukhina VA; Tarasova NA; Polenova IM
Ter Arkh; 1978; 50(9):114-8. PubMed ID: 705640
[No Abstract] [Full Text] [Related]
5. Combined immunosuppressive and anticoagulant treatment in children with glomerulonephritis and declining renal function.
Savage JM; Postlethwaite RJ; Lendon M; Houston IB; Evans DI
Int J Pediatr Nephrol; 1982 Sep; 3(3):167-73. PubMed ID: 7141788
[No Abstract] [Full Text] [Related]
6. [Treatment of various clinico-morphological variants of chronic glomerulonephritis].
Tomilina NA; Biriukova LS; Makurov AI; Ratner MIa
Ter Arkh; 1983; 55(6):61-6. PubMed ID: 6612622
[No Abstract] [Full Text] [Related]
7. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
Ratner MIa; Tomilina NA; Biriukova LS; Monchakovskiĭ SF
Ter Arkh; 1985; 57(6):69-74. PubMed ID: 4071418
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of chronic glomerulonephritis].
Ratner MIa; Tomilina NA; Gordon RI; Smirnova MP; Samokhina NM
Klin Med (Mosk); 1975 Aug; 53(8):92-9. PubMed ID: 1186099
[No Abstract] [Full Text] [Related]
9. [Results of 2-year use of the immunosuppressive drugs dipyridamole and methindol in the treatment of patients with chronic mesangiocapillary glomerulonephritis].
Kacprzyk F; Kubala L; Chrzanowski W; Pastuszko-Maryniarczyk T
Pol Tyg Lek; 1987 Aug; 42(34):1046-9. PubMed ID: 3422838
[No Abstract] [Full Text] [Related]
10. Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.
Brown CB; Wilson D; Turner D; Cameron JS; Ogg CS; Chantler C; Gill D
Lancet; 1974 Nov; 2(7890):1166-72. PubMed ID: 4139590
[No Abstract] [Full Text] [Related]
11. [Long-term use of a combination of immunosuppressants, and antiaggregant and an anticoagulant in the treatment of glomerulonephritis].
Ratner MIa; Tomilina NA; Serov VV
Ter Arkh; 1979; 51(6):43-7. PubMed ID: 473049
[No Abstract] [Full Text] [Related]
12. Focal necrotizing glomerulonephritis.
Johnson JR; McGovern VJ
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):749-68. PubMed ID: 4803316
[No Abstract] [Full Text] [Related]
13. [The effectiveness of cocktail therapy in the early treatment of children with MPGN type I, with special regard to remarkable histological improvement].
Tanizawa T; Miura K; Asada R; Matsukura H; Mase D; Inaba S; Tani M; Hara M; Higuchi A; Okada T
Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):401-12. PubMed ID: 3747251
[No Abstract] [Full Text] [Related]
14. [Criteria for the outcome of treatment of chronic glomerulonephritis and the evaluation of the effectiveness of current therapeutic methods].
Ratner MIa; Tomilina NA; Samokhina NM
Ter Arkh; 1978; 50(1):81-7. PubMed ID: 635805
[No Abstract] [Full Text] [Related]
15. [Blood coagulation in glomerulonephritis treated with heparin combined with prednisolone].
Kozhomkulova BZh; Panchenko VM; Gilunova NI
Klin Med (Mosk); 1979 Jul; 57(7):66-72. PubMed ID: 480887
[No Abstract] [Full Text] [Related]
16. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
[TBL] [Abstract][Full Text] [Related]
17. [Differentiated pathogenetic therapy of glomerulonephritis].
Belovezhdov N
Ter Arkh; 1987; 59(8):38-40. PubMed ID: 3686444
[No Abstract] [Full Text] [Related]
18. [New results concerning the effectiveness of therapy of chronic glomerulonephritis. Results of cytostatics-anticoagulants-aggregation inhibitors, cystostatics-anticoagulants-aggregation inhibitors-prednisone and cystostatics-prednisone therapy, derived from a retrospective study].
Sinn W; Ratner M; Tomilina N; Klinkmann H; Nizze H
Z Urol Nephrol; 1986 Aug; 79(8):449-57. PubMed ID: 3535293
[TBL] [Abstract][Full Text] [Related]
19. [Use of leukeran in the overall therapy of chronic glomerulonephritis in children].
Sitnitskaia IG; Bagdasarova IV; Panchenko VI
Pediatr Akus Ginekol; 1977 Dec; (6):7-9. PubMed ID: 343057
[No Abstract] [Full Text] [Related]
20. Effect of combined immunosuppressive-cytostatic treatment on antibody-dependent cellular cytotoxicity of patients with chronic glomerulonephritis.
Láng I; Fekete B; Kenéz B; Nagy ZK; Gergely P
Acta Med Acad Sci Hung; 1977; 34(4):247-50. PubMed ID: 618056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
